Worldwide Influenza Vaccines Market size is expected to exceed USD 7.5 billion by 2027.
Highlighted with 23 tables and 100 figures, this 260-page report “Worldwide Influenza Vaccines Market Size, Share, Analysis, Growth, Trends, and Forecast to 2027” is based on a comprehensive research of the worldwide influenza vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the worldwide influenza vaccines market. The report provides historical market data for 2013 – 2019, and forecasts from 2020 until 2027. A comprehensive analysis has been done on market share with the percentage of all the segments.
The Report Analyses the Market Based on Countries and Presents the Forecast in Terms of Value and Volume for the Next Seven Years. Countries Covered in the Report Include:
- United States
- Canada
- Brazil
- Germany
- France
- Italy
- Spain
- United Kingdom
- Netherlands
- Sweden
- Denmark
- Poland
- Norway
- Finland
- Ireland
- Belgium
- Australia
- New Zealand
- Japan
- China
- India
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
- Sanofi Pasteur
- GlaxoSmithKline (GSK)
- Seqirus (CSL Limited)
- AstraZeneca
- Mylan
- Gamma Vaccines Pty Ltd.
- Hualan Biological Engineering Inc.
- Shanghai Institute of Biological Products Co., Ltd.
- BioDiem
- Novavax
- BiondVax Pharmaceuticals Ltd.
- Medicago
- Moderna Inc
- Pneumagen
- Daiichi–Sankyo
- Altimmune
- FluGen
- Imutex
For More Information@ https://dpiresearch.com/influenza-vaccines-market-globally/
The report is readily available and can be dispatched immediately after payment confirmation.
Would like to place an order or any question, please feel free to contact at [email protected]
Customization of the Report:
DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.
Contact Us:
Maria Rai
Head of Business Development
DPI Research
Direct Line: +91-766-764-8693
E-mail: [email protected]
